Furosemide
Brand Names: Lasix, Lasix Onyu, Furoscix
Methodology & AI Transparency ⓘ
Furosemide Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Indications and usage: Edema Furosemide tablets are indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome.
- 2 Real-world patient consensus: 91% patient "Worth It" rating across 21 anonymous logs for Furosemide (RxNorm 310429).
- 3 Typical cash cost range: Uninsured 30-day outlay compares $5.58 wholesale mail-order against $34.50 retail pharmacy pricing.
- 4 Top reported side effects / signs: Primary clinical safety signals tracked in FAERS for Furosemide include nausea (12.2%), headache (10.8%), dizziness (6.5%).
Ask our AI Specialists anything about Furosemide
Furosemide Mechanism, CYP450 Pathways & DailyMed Monograph
Indications and usage: Edema Furosemide tablets are indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Furosemide tablets are particularly useful when an agent with greater diuretic potential is desired. Hypertension Oral furosemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents.
CLINICAL PHARMACOLOGY Investigations into the mode of action of furosemide have utilized micropuncture studies in rats, stop flow experiments in dogs and various clearance studies in both humans and experimental animals. It has been demonstrated that furosemide inhibits primarily the absorption of sodium and chloride not only in the proximal and distal tubules but also in the loop of Henle. The high degree of efficacy is largely due to the unique site of action. The action on the distal tubule is independent of any inhibitory effect on carbonic anhydrase and aldosterone.
Pharmacokinetic profiling of Furosemide demonstrates an elimination half-life of Biphasic clearance with 8–15 hr terminal t½ under Furosemide maintenance with Complete (~100%) parenteral systemic delivery for Furosemide (10 mg/mL Injection, Solution) systemic bioavailability; clearance proceeds via hepatic enzymatic processing and renal clearance proportional to creatinine clearance (furosemide), reaching clinical onset within rapid intravascular/parenteral onset within 15–45 minutes after furosemide administration.
Titration schedules for Furosemide (10 mg/mL Injection, Solution → 40 mg/1 Tablet → 10 mg/mL Injection → 80 mg/1 Tablet → 20 mg/1 Tablet) require excluding contraindications furosemide tablets are contraindicated in patients with anuria and in patients with a history of hypersensitivity to furosemide.; prior anaphylaxis, angioedema, or severe hypersensitivity to furosemide or furosemide excipients; real-world patient logs highlight nausea (12.2% of reports), headache (10.8% of reports), diarrhea (9.5% of reports) alongside a 91.00% Worth-It consensus.
Avoid overlapping loop diuretic prescriptions alongside Furosemide to prevent cumulative receptor toxicity.
Unstandardized herbal extracts may interact pharmacodynamically with Furosemide maintenance therapy.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- CONTRAINDICATIONS Furosemide tablets are contraindicated in patients with anuria and in patients with a history of hypersensitivity to furosemide.
- Prior anaphylaxis, angioedema, or severe hypersensitivity to Furosemide or Furosemide excipients
Logged Side-Effect Incidence (21 Reports)
Furosemide Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Furosemide)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Comparative effectiveness of torsemide vs furosemide in the management of heart: What a 2,859-Participant Study Found The overall WR comparison between torsemide and furosemide showed no statistically significant difference in the primary 12-month analysis. American heart journal • 2026-11-15 • Phase III Randomized Trial | N = 2,859 | 90/100 | PMID 42419438 ↗ |
| Can This Approach Help? Inside the Latest Research on An Adult Population how the body absorbs the medicine Model to Simulate Simulated furosemide exposure was consistent with published values, supporting an 80-mg dose of subcutaneous furosemide (30 mg over the first hour, then 12.5 mg/h for 4 h) for adolescents aged 12-17 years with body weight ≥... Clinical pharmacokinetics • 2025-06-15 • Phase III Randomized Trial | N = 15 | 82/100 | PMID 40360952 ↗ |
| Can This Approach Help? Inside the Latest Research on Clinical Presentation, Biomarker Trajectories, and Outcomes in Women and Men During an AHF hospitalization, women received lower doses of loop diuretic agents and achieved less weight loss with slightly lower diuretic response compared with men, despite similar symptom relief and postdischarge outcomes. JACC. Heart failure • 2025-10-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 40845614 ↗ |
Furosemide Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.2231/unit (~$6.69/30u) | Wholesale baseline |
| Mark Cuban Cost Plus Drugs (Mail-Order Generic) | Public Wholesale Price List (NADAC + 15% + pharmacy fee) | $5.58 / mo | Formulary listing ↗ |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 21 Anonymous DotMD Community Micro-Logs | $7.50 / mo | View logs ↓ |
Furosemide Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Furosemide RxNorm Concept ID | 310429 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.2231 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $5.58 / mo (Cost Plus Drugs) | Mark Cuban Cost Plus Public API |
| Real-World Patient Consensus | 91.00% Worth It (21 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Furosemide Patient Community, Cohort Filters & Dosage Logs
Deterministic Furosemide reference combining NIH RxNorm (310429), Medicaid NADAC ($0.2231/unit), and anonymous cohort outcomes (91% Worth It).
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Furosemide community threads and patient logs by age, biological sex, dosage, and treatment duration.